Volume 271, Number 35, Issue of August 30, 1996 pp. 21353-21358
©1996 by The American Society for Biochemistry and Molecular Biology, Inc.

---

Insulin Signaling in Mice Expressing Reduced Levels of Syp

(Received for publication, February 14, 1996, and in revised form, June 6, 1996)

From the Bayer Corporation, Pharmaceutical Division, Metabolic Disorders Research, West Haven, Connecticut 06516

Syp is a protein tyrosine phosphatase implicated in insulin and growth factor signaling. To evaluate the role of syp in insulin's regulation of plasma glucose, we generated knockout mice. Homozygous knockout mice die prior to day 10.5 of embryonic development. Hemizygous mice express half the levels of syp protein compared with their wild type littermates but do not display any gross morphological changes. Total body weight (age 2-10 weeks) and plasma insulin and glucose levels both in fasting and glucose-challenged states were comparable in the wild type and the hemizygous mice. No differences were observed in insulin-induced glucose uptake in soleus muscle and epididymal fat; insulin inhibition of lipolysis was also similar. We injected insulin into the portal vein of the mice to examine upstream events of the insulin signaling cascade. Tyrosine phosphorylation of insulin receptor and insulin receptor substrate-1 (IRS-1) from hemizygous tissue was similar to that of wild type tissue. Association of the p85 subunit of phosphatidylinositol 3-kinase to IRS-1 increased an average of 2-fold in both groups. We did not observe an increase of IRS-1/syp association after insulin administration, but we did note a significant basal association in both wild type and hemizygous tissue. Our results do not support a major role for syp in the acute in vivo metabolic actions of insulin.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				I. Pilecka, C. Patrignani, R. Pescini, M.-L. Curchod, D. Perrin, Y. Xue, J. Yasenchak, A. Clark, M. C. Magnone, P. Zaratin, et al. Protein-tyrosine Phosphatase H1 Controls Growth Hormone Receptor Signaling and Systemic Growth J. Biol. Chem., November 30, 2007; 282(48): 35405 - 35415. [Abstract] [Full Text] [PDF]

				A. W Stoker Protein tyrosine phosphatases and signalling J. Endocrinol., April 1, 2005; 185(1): 19 - 33. [Abstract] [Full Text] [PDF]

				G. S. Kapoor, Y. Zhan, G. R. Johnson, and D. M. O'Rourke Distinct Domains in the SHP-2 Phosphatase Differentially Regulate Epidermal Growth Factor Receptor/NF-{kappa}B Activation through Gab1 in Glioblastoma Cells Mol. Cell. Biol., January 15, 2004; 24(2): 823 - 836. [Abstract] [Full Text] [PDF]

				E. Asante-Appiah and B. P. Kennedy Protein tyrosine phosphatases: the quest for negative regulators of insulin action Am J Physiol Endocrinol Metab, April 1, 2003; 284(4): E663 - E670. [Abstract] [Full Text] [PDF]

				Y. AOKI, Z. HUANG, S. S. THOMAS, P. G. BHIDE, I. HUANG, M. A. MOSKOWITZ, and S. A. REEVES Increased susceptibility to ischemia-induced brain damage in transgenic mice overexpressing a dominant negative form of SHP2 FASEB J, October 1, 2000; 14(13): 1965 - 1973. [Abstract] [Full Text]

				Y. Boyd, H. J. Blair, P. Cunliffe, W. K. Masson, and V. Reed A Phenotype Map of the Mouse X Chromosome: Models for Human X-linked Disease Genome Res., March 1, 2000; 10(3): 277 - 292. [Abstract] [Full Text]

				H. Maegawa, M. Hasegawa, S. Sugai, T. Obata, S. Ugi, K. Morino, K. Egawa, T. Fujita, T. Sakamoto, Y. Nishio, et al. Expression of a Dominant Negative SHP-2 in Transgenic Mice Induces Insulin Resistance J. Biol. Chem., October 15, 1999; 274(42): 30236 - 30243. [Abstract] [Full Text] [PDF]

				C. Li and J. M. Friedman Leptin receptor activation of SH2 domain containing protein tyrosine phosphatase 2 modulates Ob receptor signal transduction PNAS, August 17, 1999; 96(17): 9677 - 9682. [Abstract] [Full Text] [PDF]

				H. Tang, Z. J. Zhao, X.-Y. Huang, E. J. Landon, and T. Inagami Fyn Kinase-directed Activation of SH2 Domain-containing Protein-tyrosine Phosphatase SHP-2 by Gi Protein-coupled Receptors in Madin-Darby Canine Kidney Cells J. Biol. Chem., April 30, 1999; 274(18): 12401 - 12407. [Abstract] [Full Text] [PDF]

				T. M. Saxton and T. Pawson Morphogenetic movements at gastrulation require the SH2 tyrosine phosphatase Shp2 PNAS, March 30, 1999; 96(7): 3790 - 3795. [Abstract] [Full Text] [PDF]

				M. R. Stofega, H. Wang, A. Ullrich, and C. Carter-Su Growth Hormone Regulation of SIRP and SHP-2 Tyrosyl Phosphorylation and Association J. Biol. Chem., March 20, 1998; 273(12): 7112 - 7117. [Abstract] [Full Text] [PDF]

				Z.-Q. Shi, W. Lu, and G.-S. Feng The Shp-2 Tyrosine Phosphatase Has Opposite Effects in Mediating the Activation of Extracellular Signal-regulated and c-Jun NH2-terminal Mitogen-activated Protein Kinases J. Biol. Chem., February 27, 1998; 273(9): 4904 - 4908. [Abstract] [Full Text] [PDF]